首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncology reports

缩写:ONCOL REP

ISSN:1021-335X

e-ISSN:1791-2431

IF/分区:4.7/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引8555
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ronald Neil Kostoff,Michael Brandon Briggs,Darja Kanduc et al. Ronald Neil Kostoff et al.
The devastating complications of coronavirus disease 2019 (COVID‑19) result from the dysfunctional immune response of an individual following the initial severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection. Multiple to...
Eunyoung Tak,Minhee Kim,Youngra Cho et al. Eunyoung Tak et al.
Neurofibromin 1 (NF1) is a tumor suppressor that has been previously reported to regulate RAS‑MAPK signaling. The present study investigated the possible relationship between NF1 expression and anti‑EGFR antibody (cetuximab) sensitivity i...
Nobunao Ikewaki,Vidyasagar Devaprasad Dedeepiya,Kadalraja Raghavan et al. Nobunao Ikewaki et al.
The incidence of cancer, which is the second leading cause of mortality globally, continues to increase, although continued efforts are being made to identify effective treatments with fewer side‑effects. Previous studies have reported tha...
Takahiro Inaishi,Masahiro Shibata,Takahiro Ichikawa et al. Takahiro Inaishi et al.
The platelet isoform of phosphofructokinase (PFKP) is one of the key enzymes in the glycolytic pathway. PFKP is highly expressed in several cancers, and it has been reported to be involved in the progression of cancer cells. However, its on...
Wenli Chen,Guangli Dai,Yike Qian et al. Wenli Chen et al.
The phosphatidylinositol‑3‑kinase catalytic subunit α (PIK3CA) gene is mutated in numerous human cancers. This mutation promotes the proliferation of tumor cells; however, the underlying mechanism is still not clear. In the present study...
Raffaele Frazzi,Vincenza Ylenia Cusenza,Mariaelena Pistoni et al. Raffaele Frazzi et al.
Promoter methylation represents one of the major epigenetic mechanisms responsible for the regulation of gene expression. Hypomethylating drugs are currently approved for the treatment of myelodysplastic syndromes and acute myeloid leukemia...
Bushra Zeya,Sana Nafees,Khalid Imtiyaz et al. Bushra Zeya et al.
Colon cancer is one of the most commonly diagnosed malignancies, which begins as a polyp and grows to become cancer. Diosmin (DS) and naringenin (NR) are naturally occurring flavonoids that exhibit various pharmacological activities. Althou...
Junjiang Liu,Yunxia Zhang,Shoubin Li et al. Junjiang Liu et al.
Androgen deprivation therapy (ADT) is used to treat prostate cancer (PCa). However, ADT may increase the expression of androgen receptor (AR) through the amplification of chromosome X. The gene oligophrenin 1 (OPHN1) is located in the same ...
Takafumi Shima,Kohei Taniguchi,Yoshihisa Tokumaru et al. Takafumi Shima et al.
Imatinib mesylate (imatinib) is the primary agent of choice used to treat gastrointestinal stromal tumors (GIST). However, drug resistance to imatinib poses a major obstacle to treatment efficacy. In addition, the relationship between imati...
Mengmeng Fan,Makoto Arai,Akinobu Tawada et al. Mengmeng Fan et al.
The epithelial‑stromal interaction 1 gene (EPSTI1) is known to play multiple roles in the malignant progression of breast cancer and also in some aspects of the immune responses to the tumor. However, the relevance of the gene in the onset...